These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 402923)

  • 1. Generation of reactive metabolites of N-hydroxy-phenacetin by glucoronidation and sulfation.
    Mulder GJ; Hinson JA; Gillette JR
    Biochem Pharmacol; 1977 Feb; 26(3):189-96. PubMed ID: 402923
    [No Abstract]   [Full Text] [Related]  

  • 2. Formation of chemically reactive metabolites of phenacetin and acetaminophen.
    Gillette JR; Nelson SD; Mulder GJ; Jollow DJ; Mitchell JR; Pohl LR; Hinson JA
    Adv Exp Med Biol; 1981; 136 Pt B():931-50. PubMed ID: 6953755
    [No Abstract]   [Full Text] [Related]  

  • 3. Sex differences in drug conjugation and their consequences for drug toxicity. Sulfation, glucuronidation and glutathione conjugation.
    Mulder GJ
    Chem Biol Interact; 1986 Jan; 57(1):1-15. PubMed ID: 3081267
    [No Abstract]   [Full Text] [Related]  

  • 4. UDP glucuronyltransferase and phenolsulfotransferase from rat liver in vivo and in vitro. Characterization of conjugation and biliary excretion of harmol in vivo and in the perfused liver.
    Mulder GJ; Hayen-Keulemans K; Sluiter NE
    Biochem Pharmacol; 1975 Jan; 24(1):103-7. PubMed ID: 804900
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative metabolic studies of phenacetin and structurally-related compounds in the rat.
    Smith GE; Griffiths LA
    Xenobiotica; 1976 Apr; 6(4):217-36. PubMed ID: 936643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UDP glucuronyltransferase and phenolsulfotransferase from rat liver in vivo and in vitro--IV. Species differences in harmol conjugation and elimination in bile and urine in vivo.
    Mulder GJ; Bleeker B
    Biochem Pharmacol; 1975 Aug; 24(16):1481-4. PubMed ID: 811225
    [No Abstract]   [Full Text] [Related]  

  • 7. Conversion of the N-Q-glucuronide and N-O-sulfate conjugates of N-hydroxyphenacetin to reactive intermediates.
    Mulder GJ; Hinson JA; Gillette JR
    Biochem Pharmacol; 1978; 27(12):1641-9. PubMed ID: 697905
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of glucuronidation and sulfation in tumor-bearing rats.
    Gessner T
    Biochem Pharmacol; 1974 Jul; 23(13):1809-16. PubMed ID: 4376399
    [No Abstract]   [Full Text] [Related]  

  • 9. Dose-dependent shifts in the sulfation and glucuronidation of phenolic compounds in the rat in vivo and in isolated hepatocytes. The role of saturation of phenolsulfotransferase.
    Koster H; Halsema I; Scholtens E; Knippers M; Mulder GJ
    Biochem Pharmacol; 1981 Sep; 30(18):2569-75. PubMed ID: 6946775
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactive metabolites of phenacetin and acetaminophen: a review.
    Hinson JA
    Environ Health Perspect; 1983 Mar; 49():71-9. PubMed ID: 6339229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite kinetics: formation of acetaminophen from deuterated and nondeuterated phenacetin and acetanilide on acetaminophen sulfation kinetics in the perfused rat liver preparation.
    Pang KS; Waller L; Horning MG; Chan KK
    J Pharmacol Exp Ther; 1982 Jul; 222(1):14-9. PubMed ID: 7086695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of N-hydroxy compounds by conjugation.
    Irving CC
    Xenobiotica; 1971; 1(4):387-98. PubMed ID: 5006106
    [No Abstract]   [Full Text] [Related]  

  • 13. Species-specific activation of phenacetin into bacterial mutagens by hamster liver enzymes and identification of N-hydroxyphenacetin O-glucuronide as a promutagen in the urine.
    Camus AM; Friesen M; Croisy A; Bartsch H
    Cancer Res; 1982 Aug; 42(8):3201-8. PubMed ID: 7046920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of sulfation in the rat in vivo and in the perfused rat liver.
    Mulder GJ
    Fed Proc; 1986 Jul; 45(8):2229-34. PubMed ID: 3087784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship for deacetylation of a homologous series of phenacetin analogs and their N-hydroxy derivatives.
    Estus GS; Mieyal JJ
    Drug Metab Dispos; 1983; 11(5):471-6. PubMed ID: 6138233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic evidence for multiple chemically reactive intermediates in the breakdown of phenacetin N-O-glucuronide.
    Hinson JA; Andrews LS; Gillette JR
    Pharmacology; 1979; 19(5):237-48. PubMed ID: 538078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UDP glucuronyltransferase and phenolsulfotransferase in vivo and in vitro. Conjugation of harmol and harmalol.
    Mulder GJ; Hagedoorn AH
    Biochem Pharmacol; 1974 Aug; 23(15):2101-9. PubMed ID: 4213525
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the oxidative metabolism of phenacetin in rats].
    Büch H; Pfleger K; Rummel W; Ullrich V; Hey D; Staudinger H
    Biochem Pharmacol; 1967 Dec; 16(12):2247-56. PubMed ID: 6075390
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolism of N-hydroxyphenacetin in vitro and in vivo.
    Fischbach T; Lenk W
    Xenobiotica; 1985 Nov; 15(11):915-27. PubMed ID: 4082632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p-Nitrosophenetole: a reactive intermediate of phenacetin that binds to protein.
    Hinson JA; Mays JB
    Adv Exp Med Biol; 1986; 197():691-6. PubMed ID: 3766288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.